Prevention of viral myocarditis with recombinant human leukocyte interferon α A/D in a murine model
- 31 May 1987
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 9 (6), 1320-1325
- https://doi.org/10.1016/s0735-1097(87)80472-2
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Treatment of viral myocarditis with ribavirin in an animal preparation.Circulation, 1985
- Inhibition of Virus-Induced Diabetes Mellitus by Interferon is Influenced by the Host StrainExperimental Biology and Medicine, 1983
- Effects of Interferon-Alpha on Cytomegalovirus Reactivation Syndromes in Renal-Transplant RecipientsNew England Journal of Medicine, 1983
- An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus.Circulation, 1982
- An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice.Circulation, 1982
- Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer PatientsAnnals of Internal Medicine, 1982
- Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with AcyclovirNew England Journal of Medicine, 1982
- Human leukocyte interferon produced by E. coli is biologically activeNature, 1980
- Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.The Journal of Experimental Medicine, 1976
- Virus interference. I. The interferonProceedings of the Royal Society of London. B. Biological Sciences, 1957